WallStSmart
NBY

NovaBay Pharmaceuticals Inc

NYSE MKT: NBY · HEALTHCARE · BIOTECHNOLOGY

$1.95
+22.64% today

Updated 2026-04-02

Market cap
$51.92M
P/E ratio
P/S ratio
0.16x
EPS (TTM)
$-28.50
Dividend yield
52W range
$1 – $100
Volume
1.3M

NovaBay Pharmaceuticals Inc (NBY) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$4.74M$-6.27M$-9.94M$-1.65M$2.03M$-3.14M$-6.53M$-12.97M$-15.05M$-18.56M$-12.13M$-6.27M$-5.57M$-7.93M$-4.72M$-9.19M$-6.65M$-4.26M$-5.18M$-8.43M
Capital expenditures$362000.00$663000.00$610000.00$731000.00$203000.00$119000.00$148000.00$141000.00$68000.00$123000.00$160000.00$244000.00$44000.00$19000.00$26000.00$52000.00$112000.00$19000.00$6000.00$0.00
Depreciation$74000.00$183000.00$304000.00$373000.00$427000.00$425000.00$341000.00$314000.00$232000.00$164000.00$114000.00$95000.00$266000.00$65000.00$51000.00$119000.00$483000.00$356000.00$381000.00
Stock-based comp$428000.00$983000.00$1.28M$1.40M$1.22M$1.54M$1.02M$1.04M$1.38M$1.75M$2.04M$594000.00$621000.00$701000.00$1.15M$220000.00$291000.00$148000.00$29000.00
Free cash flow$4.38M$-6.93M$-10.55M$-2.38M$1.82M$-3.26M$-6.68M$-13.11M$-15.12M$-18.68M$-12.29M$-6.51M$-5.61M$-7.95M$-4.75M$-9.24M$-6.77M$-4.28M$-5.19M$-8.43M
Investing cash flow$-5.51M$-5.66M$10.86M$-1.07M$-1.19M$-4.67M$1.36M$1.41M$2.60M$-86000.00$-160000.00$-244000.00$-44000.00$-19000.00$-26000.00$-12.04M$-112000.00$-19000.00$1.06M
Financing cash flow$3.46M$17.97M$236000.00$1.61M$-292000.00$4.70M$9.47M$9.33M$7.39M$15.60M$19.42M$201000.00$5.60M$11.70M$9.76M$16.79M$4.63M$1.91M$1.50M
Dividends paid$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$4.82M
Share repurchases
Debt repayment
Net change in cash$-3.11M$4.31M$-2.23M$-5.07M$-3.04M$7.13M$-6.31M$-15000.00$3.75M$5.01M